VILLA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 5.620
EU - Europa 2.353
AS - Asia 568
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 4
AF - Africa 2
OC - Oceania 1
Totale 8.555
Nazione #
US - Stati Uniti d'America 5.520
IT - Italia 581
DE - Germania 558
IE - Irlanda 341
SE - Svezia 300
CN - Cina 249
UA - Ucraina 190
HK - Hong Kong 183
GB - Regno Unito 112
CA - Canada 99
FI - Finlandia 61
AT - Austria 57
VN - Vietnam 55
DK - Danimarca 40
BE - Belgio 34
FR - Francia 28
IN - India 26
RU - Federazione Russa 18
TR - Turchia 18
IL - Israele 12
NL - Olanda 10
IR - Iran 8
EU - Europa 5
TW - Taiwan 5
JP - Giappone 4
BG - Bulgaria 3
GR - Grecia 3
KR - Corea 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
CH - Svizzera 2
ES - Italia 2
IQ - Iraq 2
MU - Mauritius 2
PL - Polonia 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AU - Australia 1
CL - Cile 1
CZ - Repubblica Ceca 1
HR - Croazia 1
HU - Ungheria 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
Totale 8.555
Città #
Ann Arbor 1.457
Fairfield 663
Woodbridge 518
Frankfurt am Main 485
Houston 368
Wilmington 348
Dublin 331
Chandler 269
Ashburn 265
Seattle 234
Milan 215
Cambridge 213
Hong Kong 181
Jacksonville 179
New York 149
Princeton 148
Dearborn 98
Altamura 89
Lawrence 68
Nanjing 67
Vienna 57
Ottawa 47
San Diego 42
Guangzhou 36
Brussels 31
Lachine 29
Beijing 28
Fremont 28
Dong Ket 26
Helsinki 26
Grafing 24
Andover 19
Nanchang 17
Boardman 14
Hebei 14
Shenyang 13
Toronto 13
Norwalk 12
Jiaxing 10
Shanghai 10
Kocaeli 9
London 9
Rome 9
Tianjin 8
Carate Brianza 7
Edmonton 7
Falls Church 7
Fuzhou 7
Chicago 6
Jinan 6
Kiev 6
Monza 6
San Mateo 6
Bonndorf 5
Florence 5
Hefei 5
Hyderabad 5
Kunming 5
Taizhou 5
Gessate 4
Kaohsiung 4
Lappeenranta 4
Marche 4
Melegnano 4
Napoli 4
Busto Arsizio 3
Chiswick 3
Daejeon 3
Detroit 3
Gelsenkirchen 3
Kardzhali 3
Kilburn 3
Lyngby 3
Maniago 3
Pavia 3
Philadelphia 3
Pianoro 3
Potenza 3
Shaoxing 3
Udine 3
Vimercate 3
Zanjan 3
Aachen 2
Ansbach 2
Bareggio 2
Brescia 2
Cantu 2
Cardiff 2
Caserta 2
Changsha 2
Cinisello Balsamo 2
Clearwater 2
Desio 2
Gambolò 2
Genova 2
Groningen 2
Hounslow 2
Huizen 2
Islington 2
Kiel 2
Totale 7.075
Nome #
CHRNA2 and nocturnal frontal lobe epilepsy: Identification and characterization of a novel loss of function mutation 337
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 294
Analysis of human papillomavirus (HPV) 16 variants associated with cervical infection in Italian women 287
Potassium channels in the neuronal homeostasis and neurodegenerative pathways underlying Alzheimer's disease: An update 225
Long Non-Coding RNAs and Related Molecular Pathways in the Pathogenesis of Epilepsy 222
Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing 215
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 213
The synergistic relationship between Alzheimer's disease and sleep disorders: An update 210
Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE) 210
Variants in CHRNB2 and CHRNA4 identified in patients with insular epilepsy 205
Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges 201
Molecular and imaging biomarkers in Alzheimer’s disease: A focus on recent insights 187
Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease 185
Genetic architecture and molecular, imaging and prodromic markers in dementia with lewy bodies: State of the art, opportunities and challenges 174
Potassium channels and human epileptic phenotypes: An updated overview 169
Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms 155
From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder 146
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 139
Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease 136
GSK3β genetic variability in patients with Multiple Sclerosis 136
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 136
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis 135
Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis 134
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease 129
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis 127
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation 125
Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia 124
C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia 124
C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder 124
Candidate gene analysis of selectin cluster in patients with multiple sclerosis 119
Ehlers-Danlos Syndrome classical type: A novel COL5A2 missense mutation with possible additive effect of a COL5A1 stop-gain mutation in a strongly correlated phenotype 118
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 118
Circulating miRNAs as potential biomarkers in Alzheimer’s disease 113
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 112
A novel role of cardiac inwardly rectifying potassium channels explaining autonomic cardiovascular dysfunctions in a cuprizone-induced mouse model of multiple sclerosis 111
Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder 109
Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration 106
Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson’s disease: Molecular mechanisms connecting neuroinflammation to α-synuclein spreading pathology 103
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 99
Ehlers-Danlos syndromes and epilepsy: An updated review 97
Immunoreactivity of muscarinic acetylcholine M2 and serotonin 5-HT2B receptors, norepinephrine transporter and kir channels in a model of epilepsy 97
FUS/TLS genetic variability in sporadic frontotemporal lobar degeneration 96
Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with alzheimer's disease 93
Unraveling the role of inwardly rectifying potassium channels in the hippocampus of an Aβ(1-42)-infused rat model of Alzheimer's disease 92
Causal Frontotemporal Lobar Degeneration mutations: a novel MAPT mutation associated with the clinical phenotype of Progressive nonfluent Aphasia 90
C9ORF72 repeat expansion is not detected in patients with multiple sclerosis 88
Epileptic seizures in autosomal dominant forms of Alzheimer's disease 88
The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype 85
Genetics and expression analysis of Sp4 transcription factor in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 81
Exome Sequencing in an ADSHE Family: VUS Identification and Limits 80
Circulating miRNAs as potential biomarkers in Alzheimer's disease 80
Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration? 80
Investigating cardiac morphological alterations in a pentylenetetrazol-kindling model of epilepsy 76
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 73
Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration 73
Novel exon 1 progranulin gene variant in Alzheimer's disease 73
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration 73
GRN variability contributes to sporadic frontotemporal lobar degeneration 73
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 72
MCP-1 A-2518G polymorphism: Effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels 68
CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration 68
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 66
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 66
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 66
Causal frontotemporal lobar degeneration mutations: a novel mutation in MAPT associated with non-fluent progressive aphasia phenotype 65
Transcription factor Sp1 is regulated by hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 63
A 45-year-old Italian male with p.(Gly1815Ser) FBN1 mutation causing a mild variant of Marfan syndrome: A case study 54
The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration 54
Arylsulfatase a (Asa) in parkinson’s disease: From pathogenesis to biomarker potential 49
Biomarkers for alzheimer’s disease: Where do we stand and where are we going? 47
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 42
Microfluidic platforms to unravel mysteries of alzheimer’s disease: How far have we come? 41
Tlr-mediated signal transduction and neurodegenerative disorders 41
Expression and genetic analysis of microRNAs involved in multiple sclerosis 39
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects 36
Multi-omics for the understanding of brain diseases 32
Psychosis in Parkinson’s Disease: A Lesson from Genetics 31
Homology Modelling, Molecular Docking and Molecular Dynamics Simulation Studies of CALMH1 against Secondary Metabolites of Bauhinia variegata to Treat Alzheimer’s Disease 27
Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis 26
Ocular vascular changes: Choroidal thickness as an early biomarker for Alzheimer’s disease? 26
Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease 25
Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments 21
New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders 20
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 9
Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics 6
Edaravone: A Novel Possible Drug for Cancer Treatment? 6
Totale 9.066
Categoria #
all - tutte 26.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019470 0 0 0 0 0 0 0 0 67 94 168 141
2019/20201.503 155 67 92 139 130 154 213 131 160 102 114 46
2020/20212.102 104 234 190 217 145 194 148 188 146 191 152 193
2021/20221.208 148 150 160 100 82 135 60 55 45 40 77 156
2022/20231.624 188 436 149 93 89 244 48 98 127 46 65 41
2023/20241.048 59 52 62 123 133 273 179 34 133 0 0 0
Totale 9.066